Workflow
Jill Whelan Host
icon
Search documents
茂业商业股份有限公司关于控股股东股份办理质押及解除质押的公告
Xin Lang Cai Jing· 2025-06-30 20:57
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:600828 证券简称:茂业商业公告编号:临2025-033号 茂业商业股份有限公司 关于控股股东股份办理质押及解除质押的公告 重要内容提示: ● 茂业商业股份有限公司(以下简称"茂业商业"、"公司")控股股东深圳茂业商厦有限公司(以下简 称"茂业商厦")及其一致行动人合计持有公司股份1,497,380,497 股,占上市公司总股本的86.45%。茂业 商厦及其一致行动人持有公司股份累计质押数量(本次办理质押及解押后)为408,380,000股,占其所持 有公司股份总额的29.15%,占公司总股本的23.58%。 一、股份质押情况 接控股股东茂业商厦通知,茂业商厦向上海海通证券资产管理有限公司(以下简称"海通资管")申请续 贷并签订了《最高额抵押合同》,茂业商厦将其所持有的茂业商业无限售流通股份89,200,000股质押给 海通资管,用于日常经营周转。该股票质押登记手续于近日通过中国证券登记结算有限公司办理。本次 质押基本情况如下: 1、本次股份质押基本情况 ■ 2、本次质押股份未被用作重大资产重组业绩补偿等事项的担保或其他保障用途。 3、控股股东累 ...
中工国际工程股份有限公司经营合同公告
一、合同主要内容 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同金额为17,544.03万元,该项目位于河北 省邯郸市,项目内容为咨询人向委托人提供全过程工程咨询服务,包括:项目管理、工程勘察、工程规 划及设计、工程监理、全过程造价咨询、招标代理、融资咨询和其他专项评价咨询。其中,京兴国际 (联合体牵头人)、中国中元和中元长春主要承担项目管理、工程监理、其他专项评价咨询,以及工程 规划及设计、工程勘察等工作,所承担的合同工作量对应合同金额为13,105.39万元(具体金额根据实际 完成的工作量据实计算)。服务期限为合同签订之日至该项目完成竣工验收和工程结算之日止。 二、交易对方情况介绍 河北省邯郸市百万蛋鸡农业科技产业园全过程工程咨询服务合同的交易对方为深圳宸可投资控股有限公 司,注册地址为深圳市宝安区新安街道海旺社区宝兴路88号星通大厦1507。该公司成立于2023年,为国 内领先的大型蛋品全产业链集团广东宸可资本控股集团有限公司的全资子公司。深圳宸可投资控股有限 公司与公司不存在关联关系,上一会计年度未与公司发生类似业务。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 ...
微电生理:资本赋能 竞逐全球电生理市场
自创立以来,微电生理围绕三维心脏电生理手术技术进行系统性的产品布局和应用拓展,形成了以图像 导航、精密器械及能量治疗为核心的三大技术平台。2022年8月,微电生理在科创板的成功上市,为这 家深耕电生理领域的企业注入了强劲的发展动能。 孙毅勇表示,资本的注入让公司得以在高投入、长周期的创新赛道上保持战略定力,"研发是我们的生 命线,上市为这条生命线提供了坚实的后盾,保障了新产品管线的快速推进。"2024年,公司研发投入 占营业收入比例近25%,处于行业领先水平。 借资本,强创新 产能升级与全球化布局的资金需求也在上市后得到有效满足。随着全国性集采政策的推进,电生理产品 市场需求快速释放,微电生理加速推进生产场地扩建与智能化产线改造,以应对集采带来的规模化销售 挑战。 "上市不仅解决了资金问题,更重要的是提升了企业的资源整合能力。"孙毅勇指出,资本市场的认可让 企业在供应链管理、国际合作等方面获得了更多话语权,为后续的全球化竞争奠定了基础。 ● 本报记者 罗京 依托资本引擎加速创新,借势国家集采政策实现市场份额跃升,科创板上市公司微电生理正将目光锁定 全球市场,开启国际化新征程。"我们希望用中国创新为全球心律失常 ...
多家头部公司领衔 A股回购持续增加
Core Viewpoint - The enthusiasm for stock buybacks in the A-share market remains strong, with several leading companies, such as China Communications Construction Company (CCCC), planning significant buybacks to enhance shareholder value and investor confidence [1][2]. Group 1: Buyback Plans and Amounts - CCCC plans to repurchase A-shares with a total fund of no less than 5 billion yuan and not exceeding 10 billion yuan, with a buyback price capped at 13.58 yuan per share [1]. - Shengxin Lithium Energy announced a buyback plan with a total fund of no less than 4 million yuan and not exceeding 5 million yuan, with a buyback price capped at 17.75 yuan per share, to be executed within three months [2]. - Shaanxi Jinye's actual controller proposed a buyback with a total fund of no less than 40 million yuan and not exceeding 70 million yuan [2]. Group 2: Implementation of Buyback Plans - Unisplendour announced its first buyback on June 27, repurchasing approximately 775,500 shares at a total cost of about 49.62 million yuan, with prices ranging from 63.67 to 64.28 yuan per share [3][4]. - Shengmei Shanghai executed its first buyback on June 27, repurchasing 443,400 shares at a total cost of approximately 50.01 million yuan, with prices ranging from 110.81 to 115.49 yuan per share [4][5]. Group 3: Financing for Buybacks - A total of 674 A-share companies or significant shareholders have obtained buyback financing loans amounting to approximately 134.6 billion yuan since October 2024 [1][6]. - Haiou Co. received a commitment letter for a buyback loan not exceeding 108 million yuan from a financial institution [6]. - Shanying International obtained a commitment for a buyback loan not exceeding 300 million yuan, with a loan term of 36 months [6]. Group 4: Market Insights - The use of buyback financing loans is seen as a low-cost funding option for companies and shareholders, facilitating more effective implementation of buyback and increase plans [7].
实探东阿阿胶生产一线:解码老字号的“数智密码”
Core Insights - Dong'e Ejiao is undergoing a significant digital and intelligent transformation, investing 24.48 million yuan in 2024 to integrate traditional Chinese medicine with modern digital technology [1] - The company has implemented a fully automated production line for traditional Chinese medicine oral liquids, enhancing operational efficiency and reducing labor requirements [1][2] - The introduction of AI and IoT technologies has improved quality control and operational management across various processes, including raw material supply and product development [2][3] Digital Transformation - Dong'e Ejiao's investment in digitalization includes the development of an AI-based quality control system and IoT-enabled environmental monitoring, enhancing overall production capabilities [2] - The company has achieved a raw material loss rate of 0.8% and a 30% increase in per capita output value through intelligent production processes [2] Supply Chain Optimization - The establishment of a smart supply chain system allows for precise forecasting and inventory management, reducing average inventory turnover days from 84 to 30 and decreasing obsolete materials by 50% [3] - The integration of sales and production planning has improved plan accuracy by 30%, with key product plan accuracy exceeding 90% [3] R&D and Product Development - Dong'e Ejiao has developed a product lifecycle management platform that standardizes and modularizes product data management, facilitating collaborative R&D and shortening product development cycles [3] - The company aims to address challenges in traditional Chinese medicine production, such as standardization and quality control, by creating a comprehensive digital system covering the entire supply chain [3] Industry Impact - As a representative enterprise in the health supplement industry, Dong'e Ejiao is leveraging AI and digital technologies to enhance its entire value chain, from breeding and R&D to production and consumer services [4] - The company's digital transformation efforts are expected to promote the inheritance and innovation of traditional Chinese medicine culture while exploring new growth opportunities in the industry [4]
药品追溯码全面应用重塑医药产业链格局
● 本报记者 傅苏颖 实现降本增效 7月1日起,医保药品"卖药必扫码,买药先验码,无码医保不结算"。根据国家医保局等四部门今年3月 份发布的通知,自2025年7月1日起,销售环节按要求扫码后方可进行医保基金结算。自2026年1月1日 起,所有医药机构都要实现药品追溯码全量采集上传。业内人士认为,药品追溯码的全面应用,有助于 实现医保药品全流程可追溯,加强药品流通监管,对医药产业链的生产、流通、零售及医保等环节都将 产生深远影响。 今年3月,国家医保局等四部门联合发布通知,要求加强药品追溯码在医疗保障和工伤保险领域的采集 应用。通知要求,药品上市许可持有人和生产企业应按照相关规定,对各级销售包装单元赋码,并确保 药品追溯码的准确性和唯一性。医保定点医药机构需准确采集、核验药品追溯码,并上传至全国统一的 医保信息平台、药品上市许可持有人的药品追溯系统。自2025年7月1日起,销售环节按要求扫码后方可 进行医保基金结算,对此前已采购的无追溯码药品,列入"无码库"管理,暂可进行医保结算。自2026年 1月1日起,所有医药机构都要实现药品追溯码全量采集上传。 6月30日,国家医保局微信公众号发布消息称,药品追溯码就是每 ...
上半年股权募资额增逾四倍 强监管倒逼投行告别通道思维
上半年,在市场回暖与监管重塑共同作用下,A股股权融资市场悄然迎来变革。Wind数据显示,上半年 全市场股权募资总额升至7610.29亿元,同比大增401.72%。高速扩容背后暗藏行业变局:中信证券、国 泰海通、中信建投三大券商以50.06%的股权承销份额包揽过半市场,集中度持续提升。与此同时,监 管部门半年内开出超40张投行罚单,直指尽职调查缺失、内核程序失效等行业痼疾。伴随着政策层切断 规模挂钩收费机制,投行业正经历从发行通道到风控专家的生存逻辑重构。 ● 赵中昊 谭丁豪 据中国证券报记者统计,2025年上半年,证监会、沪深北交易所、各地方证监局以及中证协出具的券商 投行业务相关罚单合计超40张,问题覆盖质控与内核失效、尽职调查缺失、收费与利益冲突等多个层 面。例如,5月下旬,沪深交易所对中信证券、国投证券、华福证券、五矿证券等采取监管警示措施, 涉及IPO、再融资、债券承销等核心业务环节。监管警示函指出,这些案例反映出部分券商在项目执行 中存在"走过场"现象,质控与内核流程未能有效发挥作用。 2025年,投行业务违规现象呈现数量增多、覆盖面扩大、责任追究趋严等特征。值得注意的是,近年来 监管部门对投行领域 ...
三大共识勾勒下半年投资蓝图券商中期策略建言紧抓AI主线
Market Overview - A-shares in the first half of 2025 experienced a range-bound trading pattern, with daily trading volume consistently above 1 trillion yuan [1] - The overall profitability of A-share listed companies is expected to improve, leading to a stabilization and recovery of ROE (Return on Equity) [1][3] Factors Supporting A-share Strength - Three main factors are anticipated to drive A-shares upward: improvement in external environment, continued domestic supportive policies, and ample market liquidity [1][2] - The potential for a synchronized economic and policy cycle among China, the US, and Europe could enhance macroeconomic resilience, possibly leading to significant market rallies [1] Policy and Economic Support - The success of A-share upward movement in the second half of 2025 is contingent on the effectiveness of fiscal policies to support economic recovery and the acceleration of existing fund utilization [2] - The real estate sector's stabilization is also a critical factor, with attention on comprehensive policy measures beyond just special bond storage [2] Liquidity and Investment Trends - The liquidity outlook for A-shares remains positive, supported by the expansion of public equity funds and the influx of medium to long-term capital [2] - There is a clear trend of individual investors reallocating wealth towards financial assets, which is expected to contribute significant incremental funds to the A-share market [2] Profitability Recovery and ROE Stabilization - A-share companies are projected to see a gradual recovery in profitability, which will support the stabilization of ROE, although the pace may be slow [3][4] - In Q1 2025, the net profit growth rate of A-share companies (excluding financial stocks) was 4.51% year-on-year, marking a significant improvement from the previous quarter [3] Sectoral Insights - The sectors expected to show higher profit growth in 2025 include consumer services, information technology, and midstream manufacturing [3] - The ongoing merger and acquisition reforms are anticipated to enhance the profitability of listed companies through industrial restructuring and integration [3] AI and Technology Investment Opportunities - The AI sector, particularly applications like AI agents and humanoid robots, is gaining attention as a key investment opportunity in the second half of 2025 [4][5] - The demand for AI-driven solutions is expected to drive capital expenditures in cloud services and related technologies, with significant potential for enterprise-level smart transformations [5]
加强党建与金融业务融合 谱写高质量发展新篇章
● 本报记者 石诗语 近年来,多家银行坚持党建引领,推动党建与业务深度融合,深刻把握金融工作的政治性、人民性。始 终牢记使命,奋力做好科技金融、绿色金融、普惠金融、养老金融、数字金融"五篇大文章",将党的建 设深度融入公司治理、经营发展、人才培养等方面。胸怀"国之大者",聚焦主责主业,不断优化金融供 给,助力经济社会高质量发展。 服务实体经济 近年来,多家银行聚焦重点领域,服务现代化产业体系建设,坚持把金融服务实体经济作为根本宗旨, 扎实做好"五篇大文章",助力经济运行持续向好,用足用好货币政策工具和一揽子金融政策,抓紧抓实 政策机遇,确保党中央重大决策部署在银行业落实落地。 例如,工商银行相关负责人向记者介绍,该行深入贯彻落实党中央、国务院决策部署,持续加大小微企 业融资支持力度,积极运用金融科技赋能,加快推进普惠金融数字化转型,畅通融资渠道,进一步提升 金融服务的可得性、便利性。该行上海分行成功推动"经营快贷"产品入驻上海市虹口区信易贷平台,支 持客户通过微信小程序、H5页面、二维码扫码等多种方式办理普惠贷款,提升客户融资体验。 又如,农业银行紧紧围绕党中央全面推进美丽中国建设的部署,聚焦美丽中国先行区建 ...
CVG Announces Successful Completion of Debt Refinancing Transactions
Globenewswire· 2025-06-30 20:50
Core Viewpoint - Commercial Vehicle Group (CVG) successfully refinanced $210 million in senior secured credit facilities, extending maturity to 2030 and enhancing financial flexibility [1][2] Group 1: Refinancing Details - The refinancing includes a $95 million senior secured term loan and a $115 million asset-based revolving credit facility [1] - The term loan matures on June 27, 2030, with interest rates ranging from SOFR plus 8.75% to SOFR plus 10.75% based on leverage ratios [3] - The ABL Facility also matures on June 27, 2030, and is subject to a borrowing base based on US and UK inventory and receivables [5][6] Group 2: Financial Flexibility and Covenants - The new facilities provide funding certainty and increased financial flexibility, supporting cost reductions and operational efficiency [2] - The term loan has a consolidated total leverage ratio covenant starting at 7.25x, with scheduled step-downs to 4.00x by September 30, 2027 [8] - A maximum capital expenditure covenant is set at $20 million per fiscal year, with a sublimit of $10 million for foreign capital expenditures [8] Group 3: Warrants and Additional Information - TCW Group affiliates received five-year warrants for the purchase of up to 3,934,776 shares of common stock at exercise prices of $1.58 and $2.07 [10] - The company is required to file a Current Report on Form 8-K with the SEC to provide further details regarding the transactions [11] - CVG is a global provider of systems and components for the commercial vehicle and electric vehicle markets [12]